Cargando…

Blood‐derived product therapies for SARS‐CoV‐2 infection and long COVID

Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is capable of large‐scale transmission and has caused the coronavirus disease 2019 (COVID‐19) pandemic. Patients with COVID‐19 may experience persistent long‐term health issues, known as long COVID. Both acute SARS‐CoV‐2 infection and long...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Junzheng, Yang, Huichuan, Yu, Ding, Yang, Xiaoming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651828/ https://www.ncbi.nlm.nih.gov/pubmed/38020714 http://dx.doi.org/10.1002/mco2.426

Ejemplares similares

Cellular tropism and antigenicity of mink-derived SARS-CoV-2 variants
por: Zhang, Li, et al.
Publicado: (2021)

Association of SARS-CoV-2 infection and persistence with long COVID
por: Yang, Chengliang, et al.
Publicado: (2023)

Analysis and Identification of Bioactive Compounds of Cannabinoids in Silico for Inhibition of SARS-CoV-2 and SARS-CoV
por: Chen, Chenxiao, et al.
Publicado: (2022)

Long-Term Health Consequences of SARS-CoV-2: Assumptions Based on SARS-CoV-1 and MERS-CoV Infections
por: Khaswal, Ashutosh, et al.
Publicado: (2022)

Gene signatures of SARS-CoV/SARS-CoV-2-infected ferret lungs in short- and long-term models
por: Liu, Hsin-Liang, et al.
Publicado: (2020)

Impact of corticosteroid therapy on outcomes of persons with SARS-CoV-2, SARS-CoV, or MERS-CoV infection: a systematic review and meta-analysis
por: Li, Huan, et al.
Publicado: (2020)

Transfusion of blood products derived from SARS-CoV-2+ donors to patients with hematological malignancies
por: Gambacorti-Passerini, Carlo, et al.
Publicado: (2021)

Retracted: Meta-analysis of Randomized Trials of Ivermectin to Treat SARS-CoV-2 Infection
por: Hill, Andrew, et al.
Publicado: (2021)

Retraction to: Meta-analysis of Randomized Trials of Ivermectin to Treat SARS-CoV-2 Infection
por: Hill, Andrew, et al.
Publicado: (2022)

Long-term effects of SARS-CoV-2 infection on human brain and memory
por: Ding, Qiulu, et al.
Publicado: (2023)

Endothelial cells are not productively infected by SARS‐CoV‐2
por: Schimmel, Lilian, et al.
Publicado: (2021)

SARS-CoV, MERS-CoV and SARS-CoV-2 infections in pregnancy and fetal development
por: de Souza Silva, Guilherme Antonio, et al.
Publicado: (2020)

Imaging findings in coronavirus infections: SARS-CoV, MERS-CoV, and SARS-CoV-2
por: Franquet, Tomas, et al.
Publicado: (2020)

Long-term infection of SARS-CoV-2 changed the body's immune status
por: Lin, Lan, et al.
Publicado: (2020)

Long COVID a New Derivative in the Chaos of SARS-CoV-2 Infection: The Emergent Pandemic?
por: Fernández-Lázaro, Diego, et al.
Publicado: (2021)

ABO blood groups and the risk of SARS-CoV-2 infection
por: Bullerdiek, Jörn, et al.
Publicado: (2022)

Changes in the Blood Viscosity in Patients With SARS-CoV-2 Infection
por: Al-kuraishy, Hayder M., et al.
Publicado: (2022)

Blood Group A Enhances SARS-CoV-2 Infection
por: Wu, Shang-Chuen, et al.
Publicado: (2022)

Blood Group A Enhances SARS-CoV-2 Infection
por: Wu, Shang-Chuen, et al.
Publicado: (2023)

Natural products as a therapy to combat against SARS-CoV-2 virus infection
por: Malviya, Shivani, et al.
Publicado: (2022)

A Review of SARS-CoV2: Compared With SARS-CoV and MERS-CoV
por: Zhou, Huan, et al.
Publicado: (2021)

The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections
por: Zhang, Yun-yu, et al.
Publicado: (2020)

Comparison of the COVID-2019 (SARS-CoV-2) pathogenesis with SARS-CoV and MERS-CoV infections
por: Fani, Mona, et al.
Publicado: (2020)

RETRACTED: Expression of Concern: “Meta-analysis of Randomized Trials of Ivermectin to Treat SARS-CoV-2 Infection”
por: Hill, Andrew, et al.
Publicado: (2021)

Vaccines and Therapies in Development for SARS-CoV-2 Infections
por: Wu, David, et al.
Publicado: (2020)

Long term persistence of coronavirus SARS-CoV-2 infection
por: Pinho, João Renato Rebello, et al.
Publicado: (2021)

Long-term neurological sequelae of SARS-CoV-2 infection
Publicado: (2022)

Long COVID after breakthrough SARS-CoV-2 infection
por: Al-Aly, Ziyad, et al.
Publicado: (2022)

Long COVID: An inevitable sequela of SARS-CoV-2 infection
por: Lai, Chih-Cheng, et al.
Publicado: (2023)

Lack of antibody-mediated cross-protection between SARS-CoV-2 and SARS-CoV infections
por: Yang, Ren, et al.
Publicado: (2020)

Susceptibility of tree shrew to SARS-CoV-2 infection
por: Zhao, Yuan, et al.
Publicado: (2020)

Omicron variants of SARS-CoV-2 and long COVID
por: Yang, Chengliang, et al.
Publicado: (2022)

SARS-CoV-2 productively infects human gut enterocytes
por: Lamers, Mart M., et al.
Publicado: (2020)

Daytime variation in SARS-CoV-2 infection and cytokine production
por: Diallo, Aïssatou Bailo, et al.
Publicado: (2021)

SARS-CoV-2 infection and red blood cells: Implications for long term symptoms during exercise
por: Misiti, Francesco
Publicado: (2021)

Immune Responses in SARS-CoV-2, SARS-CoV, and MERS-CoV Infections: A Comparative Review
por: Irani, Soussan
Publicado: (2022)

Increased LAMP1 Expression Enhances SARS-CoV-1 and SARS-CoV-2 Production in Vero-Derived Transgenic Cell Lines
por: Dolskiy, A. A., et al.
Publicado: (2022)

SARS-CoV-2 productively infects human brain microvascular endothelial cells
por: Yang, Rui-Cheng, et al.
Publicado: (2022)

Long-Term SARS-CoV-2 Antibody Seroprevalence in Blood Donors, Italy
por: Ferrari, Martina, et al.
Publicado: (2023)

Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection
por: Liang, Yanwen, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8dqdaahk2oqtmnh082pia66m27